When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Aprea Therapeutics (APRE) intends to raise $75 million in an IPO, according to an amended registration statement.
The company is developing drug treatments for MDS and acute myeloid leukemia.
APRE has achieved impressive Phase 2 trial results for its lead candidate and expects an initial readout for its pivotal Phase 3 trials by the second half of 2020.
For patient life science investors, this biopharma IPO appears promising.
Company & Technology
Boston, Massachusetts-based Aprea was founded in 2003 with a focus on developing cancer therapeutics that activate the reactive mutant